- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Sustainability publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
The State of the Art in Cardio-Oncology
Deadline: 20 December 2026
The Evolving Landscape of Squamous Cell Carcinoma of the Anal Canal: State of the Art, Current Challenges and Future Perspectives
Deadline: 15 December 2026
Advances in Nanoparticle and Exosome Technology for Delivery of Payloads in CNS Tumors
Deadline: 30 November 2026
In Vitro and In Vivo Pharmacology for Glioma Drug Discovery
Deadline: 30 November 2026
New Findings in Targeting Cancer Proteins (Second Edition)
Deadline: 30 November 2026
New Approaches to Surgical Treatment and Care for Urological Cancer
Deadline: 30 November 2026
Artificial Intelligence and Machine Learning in Lung Cancer Screening: Current Applications and Future Directions
Deadline: 30 November 2026
Advances in the Management of Pelvic Tumors: 2nd Edition
Deadline: 30 November 2026
Acute Myeloid Leukemia: Novel Therapeutic Agents and Clinical Trials
Deadline: 30 November 2026
New Clinical Insights into Gastrointestinal Cancers
Deadline: 30 November 2026
Intraoperative Radiotherapy in Cancer Treatment
Deadline: 30 November 2026
After Cancer Remission: Tracking Minimal Residual Disease and Relapse
Deadline: 30 November 2026
of 256

